SUFU 2007 - Urodynamic Outcomes of Repeated Botulinum Toxin-A Injections in the Treatment of Neurogenic Detrusor Overactivity
Thursday, 01 March 2007
read more
|
SUFU 2007 - Elevated Sensory Thresholds in the Urethra of Women with Idiopathic Overactive Bladder Consistent with C Fiber Neuropathy
Thursday, 01 March 2007
read more
|
SUFU 2007 - The Impact of Overactive Bladder (OAB) and Urinary Incontinence on Female Sexual Function Using Validated Instruments
Thursday, 01 March 2007
read more
|
SUFU 2007 - Repeat Botox A Injections and Urodynamic Findings in Neurogenic OAB: Long -Term Results of a Single Center Prospective Trial
Thursday, 01 March 2007
read more
|
SUFU 2007 - Increased Efficacy and Potency of Carbachol in Inducing Increases in Intracellular Calcium ([Ca2+]i) and Outward Potassium Currents (I0) in Overactive Bladder (OAB) and Interstitial Cystitis (IC) Human Bladder Urothelial Cells (BUC)
Thursday, 01 March 2007
read more
|
BJUI Mini Reviews - Overactive Bladder Syndrome in Older People
Thursday, 01 March 2007
This review explores current understanding of the condition and its treatment.
Login to read more...
|
European Urology - Acute Urodynamic Effects of Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients with MS
Monday, 05 February 2007
Volume 51, Issue 2, Pages 464-472 (February 2007)
Abstract -
Objectives:
The aim of this study was to investigate whether acute electrical stimulation of the posterior tibial nerve could suppress detrusor contractions in multiple sclerosis (MS) patients with neurogenic detrusor overactivity.
read more
|
Botulinum Toxin A in the Overactive Bladder: Current Status and Future Directions
Thursday, 01 February 2007
BJUI Mini Reviews - February 2007 Botulinum toxin (BTX) is a potent neurotoxin that inhibits acetylcholine release at the presynaptic cholinergic junction, inducing muscle relaxation.
read more
|
BJUI Mini Reviews - Botulinum Toxin A in the Overactive Bladder: Current Status and Future Directions
Thursday, 01 February 2007
In this review we assess current published reports to determine to what extent these questions are answered and to suggest what further research is required to determine how best to use BTX-A in the management of patients with NDO and/or IDO.
Login to read more...
|
American Urological Association Names New Director of Guidelines
Wednesday, 03 January 2007
BALTIMORE, January 2007 — The American Urological Association (AUA) has announced that Heddy Hubbard, Ph.D., M.P.H., R.N., F.A.A.N. will be the new Director of Guidelines for the association. Dr. Hubbard joined the AUA on December 28, 2006.
read more
|
European Urology - Propiverine Compared to Oxybutynin in Neurogenic Detrusor Overactivity – Results of a Randomized, Double-blind, Multicenter Clinical Study
Monday, 01 January 2007
Volume 51, Issue 1, Pages 235-242 (January 2007) Abstract - Objectives: To compare the efficacy and tolerability of propiverine and oxybutynin in patients with neurogenic detrusor overactivity.
read more
|
ICS 2006 - The Effects of Darifenacin and Tolterodine on Heart Rate (HR) in Patients with Overactive Bladder (OAB)
Wednesday, 20 December 2006
BERKELEY, CA (UroToday.com) - This Slide Presentation by Olshansky, Foote, Arguinzoniz, Lheritier, Queve-Fehling, and Steel reviews Abstract 124 from ICS 2006.
read more
|
European Urology - Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study
Thursday, 07 December 2006
Volume 50, Issue 6, Pages 1306-1315 (December 2006) Abstract - Objective: Estimate the prevalence of urinary incontinence (UI), overactive bladder (OAB), and other lower urinary tract symptoms (LUTS) among men and women in five countries using the 2002 International Continence Society (ICS) definitions.
read more
|
European Urology - New Frontiers in Intravesical Therapies and Drug Delivery
Friday, 01 December 2006
Volume 50, Issue 6, Pages 1183-1193 (December 2006) Abstract - Objectives: The intravesical route permits site-specific delivery of drugs with a reduced side-effect profile as compared to oral delivery systems, either by avoiding first-pass metabolism or by obtaining a local effect.
read more
|
European Urology - Effect of Intravesical Resiniferatoxin (RTX) on Lower Urinary Tract Symptoms, Urodynamic Parameters, and Quality of Life of Patients with Urodynamic Increased Bladder Sensation
Friday, 01 December 2006
Volume 50, Issue 6, Pages 1299-1305 (December 2006) Abstract - Objectives: Intravesical resiniferatoxin (RTX) has been used with variable efficacy in the treatment of detrusor overactivity (DO).
read more
|
Overactive Bladder (OAB) 
